FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019932894> ?p ?o ?g. }

• W2019932894 endingPage "166" @default.
• W2019932894 startingPage "162" @default.
• W2019932894 abstract "We compared the efficacy of cilostazol for the prevention of late restenosis and acute or subacute stent thrombosis with that of ticlopidine. Cilostazol has been used for antiplatelet therapy after coronary stent implantation, but the results are controversial. Patients scheduled for stent implantation were randomly assigned to receive either cilostazol (100 mg twice daily for 6 months, n=201) or ticlopidine (250 mg twice daily for 1 month, n=196). All patients also received oral aspirin (100 mg once daily for 6 months). Coronary angiography was performed at baseline and immediately and 6 months after coronary stenting. Clinical follow-up was continued up to 9 months postprocedure. There was no significant difference in the composite incidence of death, myocardial infarction, stroke, and stent thrombosis between the 2 groups [cilostazol (1.5%) versus ticlopidine (3.6%), P=0.216], but the target lesion revascularization rate per patient was significantly lower in the cilostazol group than in the ticlopidine group (22.9% vs 32.7%, P=0.030) 9 months post-coronary stenting. Medication withdrawn because of drug-related side effects tended to be higher in the ticlopidine group than that in the cilostazol group (3.5% vs 8.2%, P=0.054). At follow-up angiography, the minimal luminal diameters (2.31+/-1.06 vs 2.10+/-1.16, P=0.057) tended to be larger and the restenosis rates lower (23.3% vs 30.9%, P=0.086) in the cilostazol group than in the ticlopidine group. Aspirin plus cilostazol is a comparable antithrombotic regimen to aspirin plus ticlopidine after elective coronary stenting, but the rate of target lesion revascularization was significantly lower in the cilostazol group than in the ticlopidine group." @default.
• W2019932894 created "2016-06-24" @default.
• W2019932894 creator A5016839056 @default.
• W2019932894 creator A5034764782 @default.
• W2019932894 creator A5054023786 @default.
• W2019932894 creator A5056958603 @default.
• W2019932894 creator A5064178924 @default.
• W2019932894 creator A5069094261 @default.
• W2019932894 creator A5073931873 @default.
• W2019932894 date "2005-08-01" @default.
• W2019932894 modified "2023-10-16" @default.
• W2019932894 title "RACTS: A Prospective Randomized Antiplatelet Trial of Cilostazol Versus Ticlopidine in Patients Undergoing Coronary Stenting" @default.
• W2019932894 cites W1987971141 @default.
• W2019932894 cites W1993157664 @default.
• W2019932894 cites W1994071746 @default.
• W2019932894 cites W2002413788 @default.
• W2019932894 cites W2018859402 @default.
• W2019932894 cites W2020906145 @default.
• W2019932894 cites W2021074013 @default.
• W2019932894 cites W2064594647 @default.
• W2019932894 cites W2068153783 @default.
• W2019932894 cites W2071668258 @default.
• W2019932894 cites W2079818105 @default.
• W2019932894 cites W2103786985 @default.
• W2019932894 cites W2104337019 @default.
• W2019932894 cites W2110485927 @default.
• W2019932894 cites W2139891259 @default.
• W2019932894 cites W2153535413 @default.
• W2019932894 cites W2158324497 @default.
• W2019932894 cites W2324489407 @default.
• W2019932894 cites W2327850977 @default.
• W2019932894 cites W4247013331 @default.
• W2019932894 cites W4253509099 @default.
• W2019932894 doi "https://doi.org/10.1097/01.fjc.0000167012.82930.8f" @default.
• W2019932894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16044027" @default.
• W2019932894 hasPublicationYear "2005" @default.
• W2019932894 type Work @default.
• W2019932894 sameAs 2019932894 @default.
• W2019932894 citedByCount "42" @default.
• W2019932894 countsByYear W20199328942012 @default.
• W2019932894 countsByYear W20199328942013 @default.
• W2019932894 countsByYear W20199328942014 @default.
• W2019932894 countsByYear W20199328942015 @default.
• W2019932894 countsByYear W20199328942016 @default.
• W2019932894 countsByYear W20199328942017 @default.
• W2019932894 countsByYear W20199328942018 @default.
• W2019932894 countsByYear W20199328942020 @default.
• W2019932894 countsByYear W20199328942021 @default.
• W2019932894 countsByYear W20199328942022 @default.
• W2019932894 crossrefType "journal-article" @default.
• W2019932894 hasAuthorship W2019932894A5016839056 @default.
• W2019932894 hasAuthorship W2019932894A5034764782 @default.
• W2019932894 hasAuthorship W2019932894A5054023786 @default.
• W2019932894 hasAuthorship W2019932894A5056958603 @default.
• W2019932894 hasAuthorship W2019932894A5064178924 @default.
• W2019932894 hasAuthorship W2019932894A5069094261 @default.
• W2019932894 hasAuthorship W2019932894A5073931873 @default.
• W2019932894 hasBestOaLocation W20199328941 @default.
• W2019932894 hasConcept C126322002 @default.
• W2019932894 hasConcept C141071460 @default.
• W2019932894 hasConcept C164705383 @default.
• W2019932894 hasConcept C2777628954 @default.
• W2019932894 hasConcept C2777849778 @default.
• W2019932894 hasConcept C2778283817 @default.
• W2019932894 hasConcept C2778583881 @default.
• W2019932894 hasConcept C2778905298 @default.
• W2019932894 hasConcept C2779820409 @default.
• W2019932894 hasConcept C2780911114 @default.
• W2019932894 hasConcept C42219234 @default.
• W2019932894 hasConcept C500558357 @default.
• W2019932894 hasConcept C71924100 @default.
• W2019932894 hasConceptScore W2019932894C126322002 @default.
• W2019932894 hasConceptScore W2019932894C141071460 @default.
• W2019932894 hasConceptScore W2019932894C164705383 @default.
• W2019932894 hasConceptScore W2019932894C2777628954 @default.
• W2019932894 hasConceptScore W2019932894C2777849778 @default.
• W2019932894 hasConceptScore W2019932894C2778283817 @default.
• W2019932894 hasConceptScore W2019932894C2778583881 @default.
• W2019932894 hasConceptScore W2019932894C2778905298 @default.
• W2019932894 hasConceptScore W2019932894C2779820409 @default.
• W2019932894 hasConceptScore W2019932894C2780911114 @default.
• W2019932894 hasConceptScore W2019932894C42219234 @default.
• W2019932894 hasConceptScore W2019932894C500558357 @default.
• W2019932894 hasConceptScore W2019932894C71924100 @default.
• W2019932894 hasIssue "2" @default.
• W2019932894 hasLocation W20199328941 @default.
• W2019932894 hasLocation W20199328942 @default.
• W2019932894 hasLocation W20199328943 @default.
• W2019932894 hasOpenAccess W2019932894 @default.
• W2019932894 hasPrimaryLocation W20199328941 @default.
• W2019932894 hasRelatedWork W1974955579 @default.
• W2019932894 hasRelatedWork W1982873189 @default.
• W2019932894 hasRelatedWork W2004299432 @default.
• W2019932894 hasRelatedWork W2013821400 @default.
• W2019932894 hasRelatedWork W2018859402 @default.
• W2019932894 hasRelatedWork W2021074013 @default.
• W2019932894 hasRelatedWork W2034438272 @default.
• W2019932894 hasRelatedWork W2085907655 @default.

• next